PPIs may not reduce cancer risks

Long-term pharmacological gastric acid suppression may not reduce the risk of oesophageal cancer in patients with reflux disease, UK data has suggested.

Comparison of 809 cases of newly diagnosed oesophageal or gastric cancer with 10,000 controls highlighted a five-fold increased risk of oesophageal adenocarcinoma among patients who had taken a proton pump inhibitor (PPI) or H2 blocker for more than three years.  

This risk was only seen in patients with reflux symptoms, oesophagitis, Barrett’s oesophagus or hiatal hernia. Patients with peptic ulcers or gastroduodenal symptoms had no increased risk.  

West Sussex GP Dr Jim Price, a member of the Primary Care Society for Gastroenterology, said the findings were surprising. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

X-ray sign

Spike in TB cases prompts public health warning

Cases of TB in England have risen by 7% compared with last year, prompting a warning...

COVID-19 vaccine

GPs demand investigation as winter vaccine 'mismanagement' risks patient safety

GP leaders in England have demanded an investigation into 'mismanagement' of this...

Medical centre sign

GP 'engineering' fears as small practice contracts offered on branch-only basis

GP leaders have raised concerns over the 'engineering' of general practice after...

Close up of BMA official picket armband

SAS doctors in England to hold indicative ballot on strike action

Specialist, associate specialist and specialty (SAS) doctors in England could join...

BMA sign

BMA to oppose expansion of physician associate roles amid safety concerns

Doctors' leaders will oppose government plans to expand use of physician associates...

Doctor strikes

Public strongly back talks and new pay offer to end doctor strikes

The general public believe the government should reopen talks to end doctor strikes...